All News

Feb. 11 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Feb. 03 MicroPort EP MedTech Gets Regulatory Nod for Cardiac Imaging Catheter MT
25-10-27 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-26 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-23 Shanghai MicroPort EP MedTech Gets EU Device Certificate for Atrial Fibrillation Treatment MT
25-07-23 Shanghai MicroPort EP MedTech's H1 Profit Seen to Surge 106% MT
25-04-29 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-02-24 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-12-09 Magbot Robotic Magnetic Navigation Ablation Catheter Receives Approval by China?s NMPA CI
24-11-25 Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China CI
24-10-21 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
24-09-22 Shanghai MicroPort EP MedTech Co., Ltd.(XSSC:688351) added to S&P Global BMI Index CI
24-08-21 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
24-07-05 Shanghai MicroPort EP MedTech Forecasts Up to 828% Surge in H1 Attributable Profit MT
24-04-23 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-02-26 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
24-01-17 MicroPort EP Medtech's Columbus Cardiac Mapping System Enters EU Market MT
23-10-26 Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
No results for this search
  1. Stock Market
  2. Equities
  3. 688351 Stock
  4. News Shanghai MicroPort EP MedTech Co., Ltd.
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW